Clinical and epidemiologic burden of chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Clinical and epidemiologic burden of chronic myelogenous leukemia

Published:2004-02 Issue:1 Volume:4 Page:85-96
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Redaelli Alberto,Bell Christopher,Casagrande Jodie,Stephens Jennifer,Botteman Marc,Laskin Benjamin,Pashos Chris

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.4.1.85

Reference29 articles.

1. Deisseroth AB, Kantarjian HM, Andreeff M et al Cancer: Principles and Practice of Oncology 5th edition. Lippincott Williams & Wilkins, PA, USA (1997).

2. Ries LAG, Eisner MP, Kosary CL et al SEER Cancer Statistics Revietv 1973-1999. National Cancer Institute, MD, USA (2002).

3. The Biology of Chronic Myeloid Leukemia

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing in myeloproliferative neoplasms;Diagnostic Molecular Pathology;2024

2. 18 months follow-up of deep molecular response 4.5 (MR4.5) with nilotinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a prospective, multi-center study in China;Frontiers in Medicine;2023-11-16

3. First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia;Leukemia Research;2023-07

4. Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies;Reproduction and Fertility;2022-07-01

5. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives;Signal Transduction and Targeted Therapy;2021-05-31